Recap: Aethlon Medical Q3 Earnings
Portfolio Pulse from Benzinga Insights
Aethlon Medical (NASDAQ:AEMD) reported Q3 earnings with an EPS of $-1.37, missing estimates by 11.38% and showing no revenue change from the previous year. Last quarter, the company beat EPS estimates which led to a 7.55% share price increase the following day.
February 14, 2024 | 9:35 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Aethlon Medical reported a Q3 EPS of $-1.37, missing estimates by 11.38%, with no change in revenue from the previous year. Last quarter's EPS beat preceded a 7.55% stock price increase.
Missing earnings estimates typically leads to negative investor sentiment and can cause a short-term decrease in stock price. However, Aethlon Medical's history of a stock price increase following last quarter's earnings beat might mitigate the impact. The absence of revenue growth also contributes to a negative outlook.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100